Beverly Green, MD, MPH, is a physician scientist known for pioneering work in preventive and evidence-based medicine. With a goal of improving systems of care, she designs and evaluates programs that make effective treatment easier for patients to follow through with — and easier for providers to deliver.
Dr. Green’s research has a strong public health emphasis, targeting conditions that impact large proportions of the population — such as cardiovascular disease, cancer, and obesity — with an emphasis on leveraging technologies and systems-based care.
In 2022, Dr. Green published the results of the BP-CHECK study, which compared the accuracy and acceptability of ways to diagnose high blood pressure. With a $2.8 million award from PCORI (the Patient-Centered Outcomes Research Institute), the study compared blood pressures taken in clinic, at home, and at validated blood pressure kiosks to the 24-hour blood pressure test that is currently considered the gold standard for diagnosing hypertension. Blood pressures taken at home were the most accurate and most preferred method for diagnosing hypertension. She is working with Kaiser Permanente Washington on their efforts to integrate home blood pressure monitoring into clinical care.
Dr. Green is also leading a National Cancer Institute study that is evaluating the effectiveness of home-based human papilloma virus (HPV) kits to increase completion of cervical cancer screening.
Dr. Green’s previous research has shown that:
She is a core member of the Alliance for Reducing Cancer, Northwest, a collaborative team of cancer prevention and control experts and community stakeholders whose mission is to evaluate and respond to gaps in the Guide to Community Preventive Services (the Community Guide). She serves on the steering committee of the National Colorectal Cancer Round Table (an elected position) and is on the U.S. Validated Blood Pressure Device Review Committee.
Dr. Green was honored by Kaiser Permanente Washington in 1999 for her contributions to clinical quality improvement and was a finalist for the organization's 2004 Lifetime Achievement Award. She was an associate editor for the American Journal of Preventive Medicine from 2009 to 2014, and she is an editorial board member of the Journal of the American Board of Family Practice. She is a fellow of the American Heart Association, an honor given for contributions to the field.
Dr. Green is a clinical professor at the University of Washington School of Medicine, Department of Family Medicine, and a professor at the Kaiser Permanente Bernard J. Tyson School of Medicine, Department of Health Systems Science.
Ghai NR, Jensen CD, Merchant SA, Schottinger JE, Lee JK, Chubak J, Kamineni A, Halm EA, Skinner CS, Haas JS, Green BB, Cannizarro NT, Schneider JL, Corley DA. Primary care provider beliefs and recommendations about colorectal cancer screening in four healthcare systems. Cancer Prev Res (Phila). 2020 Nov;13(11):947-958. doi: 10.1158/1940-6207.CAPR-20-0109. Epub 2020 Jul 15. PubMed
Dublin S, Walker RL, Floyd JS, Shortreed SM, Fuller S, Albertson-Junkans LH, Harrington LB, Greenwood-Hickman MA, Green BB, Psaty BM. Renin-angiotensin-aldosterone system inhibitors and COVID-19 infection or hospitalization: a cohort study. medRxiv. 2020:2020.07.06.20120386. doi: 10.1101/2020.07.06.20120386. PubMed
Schneider JL, Rivelli JS, Gruss I, Petrik AF, Nielson CM, Green BB, Coronado GD. Barriers and facilitators to timely colonoscopy completion for safety net clinic patients. Am J Health Behav. 2020;44(4):460-472. doi: 10.5993/AJHB.44.4.8. PubMed
Meenan RT, Baldwin LM, Coronado GD, Schwartz M, Coury J, Petrik AF, West II, Green BB. Costs of two health insurance plan programs to mail fecal immunochemical tests to Medicare and Medicaid plan members. Popul Health Manag. 2021 Apr;24(2):255-265. doi: 10.1089/pop.2020.0041. Epub 2020 Jun 29. PubMed
Gupta S, Coronado GD, Argenbright K, Brenner AT, Castaneda SF, Dominitz JA, Green B, Issaka RB, Levin TR, Reuland DS, Richardson LC, Robertson DJ, Singal AG, Pignone M. Mailed fecal immunochemical test outreach for colorectal cancer screening: summary of a Centers for Disease Control and Prevention-sponsored summit. CA Cancer J Clin. 2020 Jun 25. doi: 10.3322/caac.21615. [Epub ahead of print]. PubMed
Bev Green, doctor and scientist, has tips for monitoring your blood pressure without leaving your house.
Research finds that mailing HPV test kits directly to patients increases cervical cancer screening rates.
How KPWHRI is contributing to better cancer screening and better outcomes for patients.
Research on at-home testing for HPV could improve cancer prevention and ease screening for patients.